| Active substance | Filgotinib |
| Holder | Impatients N.V. (trading as myTomorrows) on behalf of Alfasigma S.p.A. |
| Status | Running |
| Indication | Subjects with axial spondyloarthritis (axSpA) who have participated in the previous filgotinib clinical trial OLINGUITO (GLPG0634-CL-336) in Belgium and who, based on the clinical judgement of their treating physician, may benefit from continued treatment. |
| Public documents | Approbation |
| Information for the patient | |
| Informed consent | |
| Last update | 26/05/2026 |